Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹1243 Cr.
Stock P/E
29.4
P/B
—
Current Price
₹151.5
Book Value
₹ 0
Face Value
10
52W High
₹175
52W Low
₹ 114
Dividend Yield
1.65%

GPT Healthcare Overview

Business

GPT Healthcare Ltd. operates a chain of multi-specialty hospitals under the "ILS Hospitals" brand in Eastern India. Its core business involves providing comprehensive healthcare services, including primary, secondary, and tertiary medical care. The company generates revenue primarily through inpatient and outpatient services, which encompass medical and surgical treatments, diagnostics (pathology, radiology), emergency services, intensive care, and pharmacy sales. Its business model focuses on delivering quality patient care across various specialties such as cardiology, orthopedics, neurology, gastroenterology, pediatrics, and general medicine.

Revenue Mix

While specific revenue contribution by segment is not provided in the prompt, for most multi-specialty hospital chains, the primary revenue drivers are:

Inpatient Services: Typically constitutes a larger portion of revenue, including room charges, surgical fees, consultation fees, medical procedures, and intensive care.

Outpatient Services: Includes doctor consultations, minor procedures, diagnostics, and pharmacy sales for non-admitted patients.

Revenue is also derived from various medical specialties, with critical care, surgery, and specific high-demand specialties often being significant contributors.

Industry

The Indian hospital and healthcare services industry is large, growing, and fragmented, with a mix of corporate hospital chains, standalone hospitals, and government facilities. The private sector dominates specialized and tertiary care. GPT Healthcare, operating under the ILS Hospitals brand, appears to be positioned as a regional multi-specialty hospital chain, likely competing with other regional players and potentially national chains expanding into its operating geographies. Its positioning would be based on its presence in Eastern India, its range of specialties, and the quality of its medical infrastructure and personnel.

MOAT

GPT Healthcare's potential competitive advantages could include:

Regional Brand Recognition: Established presence and patient trust in its specific operating regions (Eastern India) can create a barrier for new entrants.

Doctor Talent Pool: Ability to attract and retain experienced medical professionals and specialists can be a significant differentiator.

Infrastructure & Accreditations: Modern medical facilities and accreditations can signify quality and safety.

However, strong competitive moats like large-scale network effects or proprietary technology are less common in the hospital sector, making sustained differentiation dependent on operational excellence and consistent patient outcomes.

Growth Drivers

Key factors that can drive GPT Healthcare's growth over the next 3-5 years include:

Rising Healthcare Expenditure: Increasing disposable incomes and greater health awareness among the Indian population.

Increasing Health Insurance Penetration: Growth in both government-sponsored (e.g., Ayushman Bharat) and private health insurance coverage.

Expansion & Diversification: Organic expansion into new geographies within Eastern India or inorganic growth through acquisitions.

Medical Tourism: Attracting patients from neighboring countries or other parts of India for specialized treatments.

Aging Population & Lifestyle Diseases: A growing elderly population and increasing prevalence of chronic and lifestyle-related diseases drive demand for hospital services.

Risks

Key business risks for GPT Healthcare include:

Intense Competition: Highly competitive market with existing regional players and potential entry of national chains.

Talent Acquisition & Retention: Difficulty in attracting and retaining qualified doctors, nurses, and other medical staff.

Regulatory Risks: Changes in healthcare policies, price caps on medical procedures or devices, and stringent quality regulations.

Capital Intensive Nature: Hospitals require significant capital expenditure for expansion, technology upgrades, and maintenance.

Medical Malpractice & Litigation: Risks associated with patient care, leading to potential legal liabilities and reputational damage.

Operational Efficiency: Managing costs, bed occupancy rates, and operational bottlenecks effectively.

Management & Ownership

As a listed Indian company, GPT Healthcare typically has a promoter group that holds a significant stake and plays a crucial role in strategic decision-making. The company would also have a board of directors comprising both promoter directors and independent directors, along with a professional management team responsible for day-to-day operations. The ownership structure would generally include the promoter group, institutional investors (domestic and foreign), and public shareholders. The quality of management, their vision, execution capabilities, and corporate governance practices are critical for long-term success.

Outlook

GPT Healthcare operates in a resilient and growing Indian healthcare market, driven by favorable demographic trends, increasing health awareness, and improving insurance penetration. The company's established presence in Eastern India provides a regional foundation. The potential for growth comes from organic expansion, deepening its specialty offerings, and leveraging its brand reputation. However, the sector is highly competitive, capital-intensive, and subject to regulatory changes. Challenges include intense competition for patients and medical talent, managing operational costs, and the ongoing need for capital investment. The company's ability to execute its growth strategy efficiently while maintaining high standards of patient care and managing operational risks will be key to its sustained performance.

GPT Healthcare Share Price

Live · BSE / NSE · Inception: 1989
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

GPT Healthcare Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

GPT Healthcare Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
Net Sales 172 212 243 337
Other Income 3 4 6 5
Total Income 175 216 249 342
Total Expenditure 135 176 194 264
Operating Profit 40 40 55 79
Interest 10 14 14 11
Depreciation 9 11 12 14
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 20 15 29 54
Provision for Tax 5 4 8 12
Profit After Tax 15 11 21 42
Adjustments 0 0 0 0
Profit After Adjustments 15 11 21 42
Adjusted Earnings Per Share 2.8 2 3.1 5.2

GPT Healthcare Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022
Shareholder's Funds 116 127 134 158
Minority's Interest 0 0 0 0
Borrowings 69 96 102 72
Other Non-Current Liabilities 9 17 14 20
Total Current Liabilities 55 65 60 68
Total Liabilities 249 305 311 320
Fixed Assets 158 226 220 220
Other Non-Current Assets 43 16 5 14
Total Current Assets 47 63 86 86
Total Assets 249 305 311 320

GPT Healthcare Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022
Opening Cash & Cash Equivalents 0 1 0 5
Cash Flow from Operating Activities 32 41 43 66
Cash Flow from Investing Activities -31 -54 -16 -5
Cash Flow from Financing Activities -0 12 -22 -57
Net Cash Inflow / Outflow 1 -1 4 3
Closing Cash & Cash Equivalent 1 0 5 8

GPT Healthcare Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022
Earnings Per Share (Rs) 2.78 2.03 3.14 5.22
CEPS(Rs) 4.45 4.09 6.24 6.91
DPS(Rs) 0 0.5 2 7
Book NAV/Share(Rs) 14.09 16.13 17.44 19.8
Core EBITDA Margin(%) 21.42 16.9 20.18 21.88
EBIT Margin(%) 17.94 13.67 17.56 19.33
Pre Tax Margin(%) 11.86 7 11.9 16.03
PAT Margin (%) 8.7 5.17 8.69 12.35
Cash Profit Margin (%) 13.93 10.4 13.83 16.38
ROA(%) 6.01 3.96 6.86 13.22
ROE(%) 19.72 13.47 23.35 33.06
ROCE(%) 15.17 13.05 17.14 25.56
Receivable days 23.46 24.42 25.99 16.6
Inventory Days 10.06 9.51 9.57 7.42
Payable days 281.6 269.21 187.63 114.48
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.84 0.81 0.72 0.49
EV/Core EBITDA(x) 3.61 4.28 3.19 2.12
Net Sales Growth(%) 0 23.26 14.59 39
EBIT Growth(%) 0 -6.11 47.24 53.02
PAT Growth(%) 0 -26.73 92.53 97.51
EPS Growth(%) 0 -26.75 54.25 66.26
Debt/Equity(x) 0.75 0.9 0.92 0.6
Current Ratio(x) 0.86 0.97 1.44 1.25
Quick Ratio(x) 0.77 0.87 1.33 1.14
Interest Cover(x) 2.95 2.05 3.1 5.85
Total Debt/Mcap(x) 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +39% +25% — —
Operating Profit CAGR +44% +25% — —
PAT CAGR +100% +41% — —
Share Price CAGR +3% — — —
ROE Average +33% +23% +22% +22%
ROCE Average +26% +19% +18% +18%

GPT Healthcare Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 65.57 %
FII 3.03 %
DII (MF + Insurance) 5.74 %
Public (retail) 25.66 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 65.5765.5765.5765.5765.5765.5765.5765.5765.5765.57
FII 6.685.384.74.724.484.963.22.742.813.03
DII 11.6111.8910.810.110.158.125.245.485.645.74
Public 16.1417.1618.9319.6119.7921.3525.9826.2125.9825.66
Others 0000000000
Total 100100100100100100100100100100

GPT Healthcare Peer Comparison

Hospital & Healthcare Services Edit Columns

GPT Healthcare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

GPT Healthcare Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 23%
  • Debtor days have improved from 187.63 to 114.48days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp